Endoscopic Management of Congenital Esophageal Defects and Associated Comorbidities
Copyright © 2022 Elsevier Inc. All rights reserved..
The endoscopist plays a critical role in the management of patients with congenital esophageal defects. This review focuses on esophageal atresia and congenital esophageal strictures and, in particular, the endoscopic management of comorbidities related to these conditions, including anastomotic strictures, tracheoesophageal fistulas, esophageal perforations, and esophagitis surveillance. Practical aspects of endoscopic techniques for stricture management are reviewed including dilation, intralesional steroid injection, stenting, and endoscopic incisional therapy. Endoscopic surveillance for mucosal pathology is essential in this population, as patients are at high risk of esophagitis and its late complications such as Barrett's esophagus.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Gastrointestinal endoscopy clinics of North America - 33(2023), 2 vom: 28. Apr., Seite 341-361 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yasuda, Jessica L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Congenital esophageal stricture |
|---|
| Anmerkungen: |
Date Completed 24.03.2023 Date Revised 24.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.giec.2022.11.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354539515 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354539515 | ||
| 003 | DE-627 | ||
| 005 | 20231226062437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.giec.2022.11.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1181.xml |
| 035 | |a (DE-627)NLM354539515 | ||
| 035 | |a (NLM)36948750 | ||
| 035 | |a (PII)S1052-5157(22)00108-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yasuda, Jessica L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endoscopic Management of Congenital Esophageal Defects and Associated Comorbidities |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.2023 | ||
| 500 | |a Date Revised 24.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a The endoscopist plays a critical role in the management of patients with congenital esophageal defects. This review focuses on esophageal atresia and congenital esophageal strictures and, in particular, the endoscopic management of comorbidities related to these conditions, including anastomotic strictures, tracheoesophageal fistulas, esophageal perforations, and esophagitis surveillance. Practical aspects of endoscopic techniques for stricture management are reviewed including dilation, intralesional steroid injection, stenting, and endoscopic incisional therapy. Endoscopic surveillance for mucosal pathology is essential in this population, as patients are at high risk of esophagitis and its late complications such as Barrett's esophagus | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Congenital esophageal stricture | |
| 650 | 4 | |a Dilation | |
| 650 | 4 | |a Esophageal atresia | |
| 650 | 4 | |a Esophagitis | |
| 650 | 4 | |a Surveillance | |
| 700 | 1 | |a Manfredi, Michael A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gastrointestinal endoscopy clinics of North America |d 1997 |g 33(2023), 2 vom: 28. Apr., Seite 341-361 |w (DE-627)NLM074910124 |x 1558-1950 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2023 |g number:2 |g day:28 |g month:04 |g pages:341-361 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.giec.2022.11.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2023 |e 2 |b 28 |c 04 |h 341-361 | ||